Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the present trial is to evaluate the efficacy of PRF with 1% MF in treatment of mandibular class II furcation defects and its comparison to PRF and access therapy alone.
Background: For improving efficacy and outcomes of regenerative therapy for furcation defects, various materials has been investigated in addition to access therapy. Platelet-rich fibrin (PRF) having concentrated growth factors and cytokines and Metformin (MF), an efficacious member of biguanide group are known to enhance periodontal regeneration. The aim of the present trial is to evaluate the efficacy of PRF with 1% MF in treatment of mandibular class II furcation defects and its comparison to PRF and access therapy alone.
Methods: This randomized trial was conducted on 75 patients with mandibular class II furcation defects. Defects were surgically treated with either access therapy alone (Group 1), access therapy+PRF (Group 2), and access therapy+ PRF+1% MF (Group 3). Clinical parameters like probing depth (PD), relative clinical attachment level {vertical (RVCAL) and horizontal (RHCAL)}, modified sulcus bleeding index (mSBI) and site specific plaque index (PI) were evaluated at baseline and 9 months post-operatively. Radiological assessment of bone defect fill was done at baseline and 9 months.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group 1 | Active Comparator | Scaling and Root Planing (SRP) with Open flap debridement (OFD) alone for treating furcation defect |
|
| Group 2 | Active Comparator | SRP with Open flap debridement (OFD) with Platelet rich fibrin (PRF) for treating furcation defect |
|
| Group 3 | Active Comparator | SRP with Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1% Metformin for treating furcation defect |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Open flap debridement (OFD) | Procedure | Open flap debridement (OFD) alone |
| |
| Measure | Description | Time Frame |
|---|---|---|
| Radiographic bone fill assessed in percentage | assessed in percentage | baseline to 9 months |
| Measure | Description | Time Frame |
|---|---|---|
| probing depth measured in mm | measured in mm | baseline to 9 months |
| Relative vertical attachment level measured in mm | measured in mm |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Aggressive periodontitis patients
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Government Dental College and Research Institute | Bangalore | Karnataka | 560002 | India |
Not provided
| ID | Term |
|---|---|
| D017823 | Furcation Defects |
| ID | Term |
|---|---|
| D010510 | Periodontal Diseases |
| D009059 | Mouth Diseases |
| D009057 | Stomatognathic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D004364 | Pharmaceutical Preparations |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| OFD with Platelet rich fibrin (PRF) |
| Procedure |
Open flap debridement (OFD) with Platelet rich fibrin (PRF) placement |
|
| OFD with Platelet rich fibrin (PRF)+1% Metformin (Drug) in gel form | Procedure | Open flap debridement (OFD) with Platelet rich fibrin (PRF)+1.2% Atorvastatin gel placement |
|
| baseline to 9 months |
| Relative horizontal attachment level measured in mm | measured in mm | baseline to 9 months |
| modified sulcus bleeding index | 0-3 scale | baseline to 9 months |
| plaque index | 0-3 scale | baseline to 9 months |